Global Lithotripsy Devices Market By Product Type (Extracorporeal Shock Wave Lithotripters, Intracorporeal Lithotripters, Laser Lithotripters, Electrohydraulic Lithotripters, Others) By Technology (Shock Wave Lithotripsy, Laser Lithotripsy, Others) By Application (Kidney Stones, Ureteral Stones, Bladder Stones, Gallbladder Stones, Pancreatic Stones, Others) By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics (Urology, Gastroenterology), Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview

Global Lithotripsy Devices Market size is expected to be worth around US$ 1.6 Billion by 2035 from US$ 2.5 Billion in 2025, growing at a CAGR of 4.7% during the forecast period from 2026 to 2035. In 2025, North America led the market, achieving over 41.5% share with a revenue of US$ 0.6 Billion.

The global lithotripsy devices market is witnessing steady growth due to the increasing prevalence of kidney stones and other urological disorders, coupled with the rising adoption of minimally invasive treatment procedures. Lithotripsy devices are widely utilized for the fragmentation of renal calculi, ureteral stones, and bladder stones into smaller particles that can be naturally eliminated through the urinary tract. Among the available treatment modalities, extracorporeal shock wave lithotripsy (ESWL) remains one of the most commonly preferred procedures owing to its non-invasive nature, shorter recovery period, and reduced hospitalization requirements.

The increasing burden of urolithiasis across both developed and developing economies has significantly contributed to the demand for lithotripsy procedures. According to the National Kidney Foundation, more than 500,000 people visit emergency rooms annually due to kidney stone complications in the United States, while approximately 1 in 10 individuals experience kidney stones during their lifetime.

Furthermore, studies published by the National Center for Biotechnology Information (NCBI) indicate that the prevalence of kidney stones among adults in the U.S. increased from 3.2% in 1980 to nearly 11% in recent years, highlighting the growing clinical burden associated with urinary stone diseases.

Technological advancements in laser lithotripsy, ultrasonic lithotripsy, and electrohydraulic lithotripsy systems have further enhanced treatment precision and procedural efficiency. Modern lithotripters integrated with real-time imaging systems, including ultrasound and fluoroscopy guidance, have improved stone localization and treatment outcomes while minimizing tissue damage.

Additionally, the rising geriatric population, increasing incidence of obesity and chronic kidney disease (CKD), and growing awareness regarding early diagnosis of kidney disorders are supporting market expansion. The prevalence of chronic kidney disease globally is estimated at 11–13%, while nearly 37 million adults in the United States are affected by CKD, according to healthcare data published by the National Kidney Foundation.

Key Takeaways

• Market Size: Lithotripsy Devices Market size is expected to be worth around US$ 1.6 Billion by 2035 from US$ 2.5 Billion in 2025.
• Market Share: The market growing at a CAGR of 4.7% during the forecast period from 2026 to 2035.
• Product Type Analysis: Extracorporeal Shock Wave Lithotripters dominated the market in 2025, accounting for 62.8% of the total market share.
• Technology Analysis: Shock Wave Lithotripsy emerged as the leading technology segment in 2025 and held 58.4% of the global market share.
• Application Analysis: Kidney Stones accounted for the largest market share of 48.5% in 2025.
• End User Analysis: Hospitals dominated the global market in 2025 and accounted for 55.9% of the total market share.
• Regional Analysis: In 2025, North America led the market, achieving over 41.5% share with a revenue of US$ 0.6 Billion.

Product Type Analysis

The product type segment of the global Lithotripsy Devices Market is categorized into Extracorporeal Shock Wave Lithotripters, Intracorporeal Lithotripters, Laser Lithotripters, Electrohydraulic Lithotripters, and Others. Extracorporeal Shock Wave Lithotripters dominated the market in 2025, accounting for 62.8% of the total market share.

The segment growth is primarily attributed to the widespread adoption of non-invasive treatment procedures for urinary stone management, lower patient recovery time, and reduced hospitalization requirements. These devices are extensively utilized across hospitals and specialty urology centers owing to their procedural efficiency and lower complication rates.

Intracorporeal Lithotripters are witnessing steady adoption due to their high precision in fragmenting complex and hard stones during endoscopic procedures. Laser Lithotripters are expected to register notable growth driven by increasing preference for minimally invasive surgeries and technological advancements in holmium laser systems.

Electrohydraulic Lithotripters continue to maintain demand in selected clinical applications due to their strong fragmentation capability. The Others segment, including ultrasonic lithotripters and hybrid systems, is also expanding gradually with ongoing innovation in stone management technologies and increasing procedural volumes globally.

Technology Analysis

Based on technology, the Lithotripsy Devices Market is segmented into Shock Wave Lithotripsy, Laser Lithotripsy, and Others. Shock Wave Lithotripsy emerged as the leading technology segment in 2025 and held 58.4% of the global market share.

The dominance of this segment is supported by the increasing preference for non-invasive kidney stone treatment procedures, high procedural success rates, and broad clinical acceptance across developed and emerging healthcare markets. The technology enables effective fragmentation of stones without requiring surgical incisions, thereby reducing patient discomfort, treatment costs, and post-operative complications.

Laser Lithotripsy represents the fastest-growing technology segment owing to the rising utilization of flexible ureteroscopy and advancements in laser energy delivery systems. The growing adoption of holmium:YAG and thulium fiber laser technologies has significantly improved treatment precision, procedural efficiency, and stone clearance outcomes.

In addition, increasing prevalence of recurrent urolithiasis and rising demand for minimally invasive treatment approaches are accelerating segment expansion. The Others segment includes electrohydraulic and ultrasonic lithotripsy technologies, whic“h continue to witness moderate demand in specialized clinical procedures. Continuous technological innovations and increasing investments in advanced urology infrastructure are expected to support long-term market growth across all technology categories.

Application Analysis

Based on application, the Lithotripsy Devices Market is segmented into Kidney Stones, Ureteral Stones, Bladder Stones, Gallbladder Stones, Pancreatic Stones, and Others. Kidney Stones accounted for the largest market share of 48.5% in 2025.

The dominance of the segment is mainly driven by the rising global prevalence of nephrolithiasis, increasing incidence of obesity and dehydration-related disorders, and growing adoption of minimally invasive stone removal procedures. The high patient volume requiring recurrent stone management procedures has further strengthened demand for lithotripsy devices in kidney stone treatment applications.

Ureteral Stones represent a significant market segment due to the increasing use of ureteroscopic lithotripsy procedures and advancements in endoscopic treatment technologies. Bladder Stones and Gallbladder Stones segments are also experiencing steady growth owing to the rising geriatric population and growing incidence of metabolic disorders.

Pancreatic Stones treatment applications are gradually expanding due to increasing awareness regarding chronic pancreatitis management and availability of advanced endoscopic lithotripsy systems. The Others segment includes salivary gland stones and rare calcification disorders, which contribute a comparatively smaller market share. Increasing healthcare expenditure and expanding access to advanced urological care are expected to support application segment growth globally.

End User Analysis

Based on end user, the Lithotripsy Devices Market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics (Urology, Gastroenterology), and Others. Hospitals dominated the global market in 2025 and accounted for 55.9% of the total market share.

The segment leadership is attributed to the high volume of lithotripsy procedures performed in hospital settings, availability of advanced diagnostic and surgical infrastructure, and presence of skilled healthcare professionals. Hospitals also benefit from greater patient preference for comprehensive treatment facilities and emergency care support during complex stone management procedures.

Ambulatory Surgical Centers are gaining traction due to the increasing shift toward outpatient minimally invasive procedures and shorter recovery durations. These facilities offer cost-effective treatment alternatives and reduced hospitalization expenses, thereby supporting segment growth. Specialty Clinics, including urology and gastroenterology centers, are witnessing rising demand owing to their specialized expertise, faster procedural turnaround, and growing adoption of technologically advanced lithotripsy systems.

The Others segment includes academic research institutes and smaller healthcare facilities contributing to niche procedural demand. Rising healthcare investments, increasing prevalence of urolithiasis, and expansion of specialized treatment centers are expected to drive sustained growth across all end-user segments during the forecast period.

Key Market Segments

By Product Type

• Extracorporeal Shock Wave Lithotripters
• Intracorporeal Lithotripters
• Laser Lithotripters
• Electrohydraulic Lithotripters
• Others

By Technology

• Shock Wave Lithotripsy
• Laser Lithotripsy
• Others

By Application

• Kidney Stones
• Ureteral Stones
• Bladder Stones
• Gallbladder Stones
• Pancreatic Stones
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics (Urology, Gastroenterology)
• Others

Driving Factors

The growth of the Lithotripsy Devices market is primarily driven by the rising global burden of kidney stone disease and the increasing preference for minimally invasive treatment procedures. According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 11% of men and 6% of women in the United States experience kidney stones at least once during their lifetime. The prevalence of urinary stones has increased significantly from 3.8% in 1970 to nearly 11% by 2022 in the U.S., reflecting a substantial increase in patient volume requiring treatment.

Extracorporeal Shock Wave Lithotripsy (ESWL) has emerged as a preferred treatment because it is non-invasive and enables faster recovery compared with conventional surgery. Healthcare providers are increasingly adopting lithotripsy systems due to shorter hospital stays, reduced surgical complications, and improved patient outcomes.

Rising obesity rates, dehydration, dietary changes, and diabetes prevalence are further contributing to higher incidences of urolithiasis globally. In addition, increasing healthcare expenditure and growing availability of advanced urology infrastructure in hospitals are supporting wider adoption of lithotripsy devices across developed and emerging healthcare markets worldwide.

Trending Factors

A significant trend in the Lithotripsy Devices market is the growing adoption of technologically advanced and image-guided lithotripsy systems. Healthcare facilities are increasingly integrating real-time imaging technologies such as ultrasound and CT-based guidance to improve stone targeting accuracy and treatment efficiency.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), accurate measurement and localization of kidney stones are becoming increasingly important for selecting appropriate treatment approaches, leading to greater demand for advanced lithotripsy platforms.

Another major trend is the development of next-generation non-invasive lithotripsy technologies such as Burst Wave Lithotripsy (BWL), which utilizes harmonic ultrasound bursts instead of conventional shock waves. These innovations are designed to reduce tissue damage and improve patient comfort. Additionally, portable and compact lithotripsy systems are gaining traction in ambulatory surgical centers and outpatient clinics due to lower operational costs and faster treatment procedures.

The market is also witnessing increasing integration of artificial intelligence and automated imaging systems for stone detection and treatment planning. Furthermore, healthcare providers are emphasizing outpatient-based urological care, which is accelerating demand for efficient lithotripsy devices capable of reducing hospitalization time and improving procedural productivity.

Restraining Factors

The Lithotripsy Devices market faces significant restraints due to the high cost of advanced lithotripsy systems and procedural limitations associated with shock wave therapy. Modern extracorporeal shock wave lithotripsy systems involve substantial capital investment, which limits adoption among small healthcare facilities and hospitals in low- and middle-income countries. In addition, maintenance costs, imaging integration expenses, and the requirement for skilled urologists further increase operational expenditures for healthcare providers.

Clinical limitations also restrict broader market penetration. According to clinical studies published by the National Center for Biotechnology Information (NCBI), ESWL may be less effective than percutaneous nephrolithotomy (PCNL) for larger kidney stones below 30 mm and often requires additional treatment sessions. Some patients experience incomplete stone fragmentation, recurrence, bleeding, urinary obstruction, or infection following lithotripsy procedures.

Moreover, hard stones and stones larger than 1.5 cm may respond poorly to ESWL treatment, necessitating alternative surgical interventions. These procedural limitations reduce treatment efficiency in complex cases. Reimbursement challenges and unequal access to advanced urology care in developing regions also continue to hinder market expansion, particularly in rural healthcare systems with limited medical infrastructure and specialized professionals.

Opportunity

The Lithotripsy Devices market presents substantial growth opportunities due to increasing healthcare investments, rising awareness regarding kidney stone treatment, and growing demand for non-invasive urological procedures in emerging economies. Rapid urbanization, changing dietary habits, and increasing temperatures linked with dehydration are contributing to a higher prevalence of kidney stones, particularly in Asia-Pacific and Middle Eastern countries. According to the National Institutes of Health (NIH), nearly 1 in 10 individuals may develop kidney stones during their lifetime, creating a large target patient population for lithotripsy procedures.

Governments and healthcare organizations are increasingly focusing on expanding access to advanced medical technologies and improving urology treatment infrastructure. The shift toward outpatient and ambulatory care settings is creating favorable opportunities for portable and compact lithotripsy systems.

Additionally, ongoing research into advanced ultrasound-based fragmentation technologies, including Burst Wave Lithotripsy, is expected to improve procedural safety and treatment success rates. The growing elderly population, which is more vulnerable to urinary tract disorders, further supports future market demand. Increasing adoption of AI-enabled imaging and automated treatment planning systems also offers opportunities for manufacturers to develop highly precise and efficient lithotripsy devices for next-generation urological care.

Regional Analysis

North America dominated the global Lithotripsy Devices Market in 2025, accounting for over 41.5% of the total market share and generating revenue of approximately US$ 0.6 billion. The regional market growth is primarily driven by the high prevalence of kidney stones and urological disorders, increasing adoption of minimally invasive treatment procedures, and the presence of advanced healthcare infrastructure across the United States and Canada.

The strong availability of technologically advanced lithotripsy systems, coupled with favorable reimbursement policies and rising healthcare expenditure, has further supported market expansion in the region. Additionally, the growing elderly population, which is more susceptible to urinary tract disorders, continues to contribute significantly to the demand for lithotripsy devices.

The presence of leading medical device manufacturers and continuous investments in research and development activities have accelerated product innovation and commercialization in North America. Hospitals and specialty urology centers in the region are increasingly integrating extracorporeal shock wave lithotripsy (ESWL) and laser lithotripsy technologies to improve treatment efficiency and patient outcomes.

Furthermore, rising awareness regarding early diagnosis and treatment of kidney stone diseases, along with increasing procedural volumes, is expected to sustain the region’s market leadership during the forecast period.

Key Regions and Countries

North America

• The US
• Canada

Europe

• Germany
• France
• The U.K.
• Italy
• Spain
• Russia & CIS
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• ASEAN
• Australia & New Zealand
• Rest of Asia Pacific

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa

Latin America

• Brazil
• Mexico
• Rest of Latin America

Key Players Analysis

The competitive landscape of the Lithotripsy Devices Market is characterized by the presence of several established medical device manufacturers focusing on technological advancements, product innovation, and strategic collaborations to strengthen their market position.

Key players are actively investing in research and development activities to introduce advanced laser and extracorporeal shock wave lithotripsy systems that enhance treatment precision, efficiency, and patient safety. Companies are also emphasizing the integration of minimally invasive technologies and digital imaging capabilities to improve clinical outcomes and reduce procedural complications.

Market participants are pursuing mergers, acquisitions, and partnerships with hospitals and specialty clinics to expand their geographical presence and customer base. In addition, increasing regulatory approvals for innovative urology devices are supporting product commercialization across developed and emerging markets.

Leading companies are further focusing on expanding production capacities and enhancing after-sales services to maintain competitive advantage. The market remains moderately consolidated, with global players competing on the basis of product quality, technological capabilities, pricing strategies, and distribution networks.

Market Key Players

• Boston Scientific Corporation
• Olympus Corporation
• Dornier MedTech GmbH
• Siemens Healthineers AG
• Medispec Ltd.
• Richard Wolf GmbH
• STORZ Medical AG
• Elmed Electronics & Medical Industry
• DirexGroup
• Allengers Medical Systems Ltd.
• EDAP TMS S.A.
• Cook Medical LLC
• C. R. Bard Inc. (BD)
• Karl Storz SE & Co. KG
• EMS Electro Medical Systems S.A.
• Others

Recent Developments

• Boston Scientific Corporation (January, 2025) – Boston Scientific signed a definitive agreement to acquire Bolt Medical, a developer of an advanced intravascular lithotripsy (IVL) laser platform for complex coronary and peripheral arterial disease, in a deal valued at up to $664 million, marking Boston’s formal entry into IVL and reinforcing its structural heart and PAD portfolio strategy.
• Olympus Corporation (January, 2026) – Olympus issued customer information regarding repair actions for the ShockPulse‑SE Lithotripsy System generator, reflecting ongoing post‑market quality management and lifecycle support for its intracorporeal lithotripsy installed base in urology and related settings.
• Dornier MedTech GmbH (September, 2025) – Dornier MedTech’s U.S. organization promoted the Dornier Thulio laser platform for in‑vivo stone lithotripsy at major urology meetings in North America, emphasizing AI‑assisted laser lithotripsy workflows and reinforcing its positioning as a premium, minimally invasive stone‑care partner to hospitals and high‑volume urology centers.
• Medispec Ltd.: Across 2025–2026, Medispec continues to be cited in market and technology reports as a key ESWL vendor, but no distinct, dated 2025–2026 acquisition, partnership, or major launch announcement could be confirmed from open sources.

Report Scope